Bringing the fundamentals into focus…
Back to Erasca, Inc.
How Erasca, Inc. stacks up
ERAS · against 552 other Healthcare companies listed in US-listed
Overall
35/ 100
Below the middle of the pack.
Ranked #358 of 553 · scores higher than 33% of peers
Bars: peers in each 10-point band of the overall score142 peers with an overall score of 30–39, including ERAS · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around ERAS| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 358 | 1.7B USD | 35 | 43 | 34 | 35 | 2 / 2 | |
| 358 | 356M USD | 35 | 56 | 46 | 35 | 2 / 2 | |
| 358 | 3.4B USD | 35 | 8 | — | 12 | 0 / 2 | |
| 358 | 12.3B USD | 35 | 48 | 33 | 40 | 2 / 2 | |
| 358 | 5.1B USD | 35 | 8 | — | 12 | 0 / 2 | |
| 358 | 996M USD | 35 | 8 | — | 9 | 0 / 2 | |
| 358 | 332M USD | 35 | 0 | — | 8 | 0 / 2 | |
| 358 | 10.8B USD | 35 | 49 | 31 | 41 | 2 / 2 | |
| 358 | 758M USD | 35 | 73 | 44 | 19 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score